| Ident. | Authors (with country if any) | Title |
|---|
| 000186 (2020) |
Catalina Sanchez-Alvarez [États-Unis] ; Matthew Koster [États-Unis] ; Ali Duarte-García [États-Unis] ; Kenneth J. Warrington [États-Unis] | Disease progression of Takayasu arteritis in two patients treated with tocilizumab. |
| 000227 (2020) |
Tomohiro Koga ; Naoko Hagimori [Japon] ; Shuntaro Sato [Japon] ; Shinpei Morimoto [Japon] ; Naoki Hosogaya [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi Kawakami | An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial. |
| 000275 (2019) |
Kentaro Chino [Japon] ; Tsuneo Kondo [Japon] ; Ryota Sakai [Japon] ; Shuntaro Saito [Japon] ; Yusuke Okada [Japon] ; Akiko Shibata [Japon] ; Takahiko Kurasawa [Japon] ; Ayumi Okuyama [Japon] ; Hirofumi Takei [Japon] ; Koichi Amano [Japon] | Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study. |
| 000356 (2019) |
Kenji Oku [Japon] ; Tatsuya Atsumi [Japon] | Rheumatology practice in Japan: challenges and opportunities. |
| 000363 (2019) |
Yoshikazu Nakaoka | Response to: 'Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis' by Lee and Song. |
| 000365 (2019) |
Yoshikazu Nakaoka [Japon] | Response to: 'Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis' by Liebling et al. |
| 000485 (2019) |
Young Ho Lee [Corée du Sud] ; Gwan Gyu Song [Corée du Sud] | Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis. |
| 000502 (2019) |
Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon] | Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study. |
| 000504 (2019) |
Masakazu Kondo [Japon] ; Hisakata Yamada [Japon] | Drug survival rates of biological disease-modifying antirheumatic drugs and Janus kinase-inhibitor therapy in 801 rheumatoid arthritis patients: a 14 year-retrospective study from a rheumatology clinic in Japan. |
| 000532 (2019) |
Katsuhiko Takabayashi [Japon] ; Fumihiko Ando [États-Unis] ; Takahiro Suzuki [Japon] | Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data. |
| 000570 (2019) |
Emily J. Liebling [États-Unis] ; Rosemary Peterson [États-Unis] ; Teresa Victoria [États-Unis] ; Jon M. Burnham [États-Unis] | Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis. |
| 000589 (2019) |
Tomohiro Koga [Japon] ; Remi Sumiyoshi [Japon] ; Atsushi Kawakami [Japon] ; Kazuyuki Yoshizaki [Japon] | A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease. |
| 000709 (2018) |
Tatsuya Atsumi [Japon] ; Keishi Fujio [Japon] ; Kunihiro Yamaoka [Japon] ; Minako Tomobe [Japon] ; Kazuyuki Kuroyanagi [Japon] ; Hideto Kameda [Japon] | Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting. |
| 000737 (2018) |
Tatsuya Atsumi [Japon] ; Yoshiaki Ando [Japon] ; Shinichi Matsuda [Japon] ; Shiho Tomizawa [Japon] ; Riwa Tanaka [Japon] ; Nobuhiro Takagi [Japon] ; Ayako Nakasone [Japon] | Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database. |
| 000827 (2018) |
Yasuaki Okuda [Japon] ; Toshiyuki Yamada [Japon] ; Mitsuharu Ueda [Japon] ; Yukio Ando [Japon] | First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan. |
| 000844 (2018) |
Yoshikazu Nakaoka [Japon] ; Mitsuaki Isobe [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Shumpei Yokota [Japon] ; Akira Nomura [Japon] ; Seitaro Yoshida [Japon] ; Norihiro Nishimoto [Japon] | Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). |
| 000874 (2018) |
Yuki Shono [Japon] ; Masahiro Kamata [Japon] ; Shintaro Takeoka [Japon] ; Tetsuya Ikawa [Japon] ; Mihoko Tateishi [Japon] ; Saki Fukaya [Japon] ; Kotaro Hayashi [Japon] ; Atsuko Fukuyasu [Japon] ; Takamitsu Tanaka [Japon] ; Takeko Ishikawa [Japon] ; Takamitsu Ohnishi [Japon] ; Kurumi Asako [Japon] ; Hajime Kono [Japon] ; Yayoi Tada [Japon] | Cutaneous sarcoidosis in a patient with rheumatoid arthritis receiving tocilizumab. |
| 000881 (2018) |
Tomohiro Koga [Japon] ; Shuntaro Sato [Japon] ; Junya Miyamoto [Japon] ; Naoko Hagimori [Japon] ; Yurika Kawazoe [Japon] ; Kumiko Arinaga [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi Kawakami [Japon] | Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial. |
| 000A29 (2017) |
Shoichi Kaneshiro [Japon] ; Kosuke Ebina [Japon] ; Makoto Hirao [Japon] ; Hideki Tsuboi [Japon] ; Masataka Nishikawa [Japon] ; Akihide Nampei [Japon] ; Yoshio Nagayama [Japon] ; Koichiro Takahi ; Takaaki Noguchi [Japon] ; Hajime Owaki [Japon] ; Jun Hashimoto [Japon] ; Hideki Yoshikawa [Japon] | The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab. |
| 000A87 (2017) |
Takayuki Katsuyama [Japon] ; Ken-Ei Sada [Japon] ; Minglu Yan [Japon] ; Sonia Zeggar [Japon] ; Sumie Hiramatsu [Japon] ; Yoshia Miyawaki [Japon] ; Keiji Ohashi [Japon] ; Michiko Morishita [Japon] ; Haruki Watanabe [Japon] ; Eri Katsuyama [Japon] ; Mariko Takano-Narazaki [Japon] ; Noriko Toyota-Tatebe [Japon] ; Katsue Sunahori-Watanabe [Japon] ; Tomoko Kawabata [Japon] ; Kohei Miyake [Japon] ; Toru Kiguchi ; Jun Wada [Japon] | Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents. |
| 000A94 (2017) |
Eiichi Tanaka [Japon] ; Eisuke Inoue [Japon] ; Rei Yamaguchi [Japon] ; Yoko Shimizu [Japon] ; Akiko Kobayashi [Japon] ; Naoki Sugimoto [Japon] ; Daisuke Hoshi [Japon] ; Kumi Shidara [Japon] ; Eri Sato [Japon] ; Yohei Seto [Japon] ; Ayako Nakajima [Japon] ; Shigeki Momohara [Japon] ; Atsuo Taniguchi [Japon] ; Hisashi Yamanaka [Japon] | Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan. |
